Healthy Living/WellnessEli Lilly's Jardiance Diabetes Treatment Steals Market Share From Rival Drugs Eli Lilly's new diabetes treatment Jardiance stole market share from its rivals. The increased market share of 25 percent of new U.S. patients was attributed to clinical trial data showing fewer deaths among type 2 diabetics by 32 percent.by Katrina Pascual
Healthy Living/WellnessJohnson & Johnson Advanced Multiple Myeloma Drug Darzalex Wins Accelerated FDA Approvalby Katherine Derla
Healthy Living/WellnessRevolutionary HIV Treatment Could Be Underway As Clinical Trial Shows Promising Result For Combination Drugby Katherine Derla
Healthy Living/WellnessJohnson & Johnson Starts Clinical Trial Of Ebola Vaccine In Sierra Leoneby Rhodi Lee
Healthy Living/WellnessJohnson & Johnson Calls On Ethicists To Weigh In On Drug Trialsby Dianne Depra
Healthy Living/WellnessIBM Establishes Watson Health Cloud With Apple, J&J, And Medtronicby Dianne Depra
Healthy Living/WellnessBoston Scientific, Johnson & Johnson Bury The Hatchet With $600 Million Settlementby Dianne Depra
Healthy Living/WellnessJohnson & Johnson halts sale of power morcellators for fibroid surgeryby Rhodi Lee
Healthy Living/WellnessFDA shows no love for Johnson & Johnson Xarelto blood thinner, rejects expanded use for 3rd timeby Randell Suba
Master Google Assistant on Android: Top Google Assistant Tips, Powerful Voice Commands, and Must-Know AI Features
'Roblox' Leveling Tips: How to Level Up Fast in 'Roblox' with the Ultimate XP Guide That Works Everywhere
Master Your Dual Monitor Setup: Step-by-Step Guide to Connect Two Monitors and Extend Your Screen Using Computer Display Settings